1-8 of 8
Andrés López
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Follow-up of Patients with HIV-Related Diffuse Large B-Cell Lymphoma (DLBCL) Treated in the Phase II Study with Rituximab and CHOP (R-CHOP)

Josep-Maria Ribera, MD, PhD, Mireia Morgades, Albert Oriol, Eva González-Barca, MD, Pilar Miralles, Armando Lopez-Guillermo, Santiago Gardella, Andrés López, Eugènia Abella, Blanca Xicoy, MD, Marta Garcia, Evarist Feliu, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4980.
https://doi.org/10.1182/blood.V118.21.4980.4980
Published: 2011
Journal Articles

Rituximab Plus Gemcitabine and Oxaliplatin as Salvage Therapy In Patients with Relapsed/Refractory Mantle-Cell Lymphoma.

Mercedes Gironella, MD, Andrés López, MD, Abrisqueta Pau, MD, Jaramillo Anny, MD, Purroy Noelia, MD, Francesc Bosch, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2825.
https://doi.org/10.1182/blood.V116.21.2825.2825
Published: 2010
Journal Articles

Predictive Value for Event-Free Survival of Interim 18F-FDG-PET In Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 6 Cycles of Dose-Dense R-CHOP-14 Immunochemotherapy Plus Pegfilgrastim as First-Line Treatment: An Open-Label Clinical Trial In Spain.

Eva González-Barca, Miguel Canales, MD, PhD, María Jesús Vidal, Albert Oriol, Antonio Salar, Joan Bargay, Montse Cortés, Juan Coya, José Francisco Tomás, Andrés López, José Javier Sánchez, Eva Donato, Andrés Llorente, Secundino Ferrer, Dolores Caballero
Journal: Blood
Blood (2010) 116 (21): 2793.
https://doi.org/10.1182/blood.V116.21.2793.2793
Published: 2010
Journal Articles

Title:Dose-Adjusted EPOCH Plus Rituximab (DA-EPOCH-R) in Untreated Patients with Poor Risk Large B-Cell Lymphoma. A Phase 2 Study Conducted by the Spanish PETHEMA Group.

Noelia Purroy, Andrés López, Teresa Vallespi, MD.PhD., Mercedes Gironella, Juan Bergua, MD, Juan Manuel Sancho, MD
Journal: Blood
Blood (2009) 114 (22): 2701.
https://doi.org/10.1182/blood.V114.22.2701.2701
Published: 2009
Journal Articles

Interim and End-of-Treatment 18F-FDG-PET Evaluation of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 6 Cycles of Dose-Dense R-CHOP-14 Immunochemotherapy Plus Pegfilgrastim for First-Line Treatment: An Open-Label Clinical Trial in Spain.

Eva Gonzalez-Barca, Miguel Canales, Antonio Salar, Albert Oriol, María Jesús Vidal, Joan Bargay, Montse Cortés, J. Coya, Jose Francisco Tomas, Andrés López, José Javier Sánchez, Eva Donato, Andrés Llorente, Secundino Ferrer, Dolores Caballero
Journal: Blood
Blood (2009) 114 (22): 3692.
https://doi.org/10.1182/blood.V114.22.3692.3692
Published: 2009
Journal Articles

Malignant Lymphoma in Primary Sjögren Syndrome: Incidence and Risk Factors.

Andrés López, Roser Solans-Laque, Josep A Bosch-Gil, Mercedes Gironella, Noelia Purroy, Campillo Marta, Teresa Vallespi, MD.PhD..
Journal: Blood
Blood (2009) 114 (22): 4991.
https://doi.org/10.1182/blood.V114.22.4991.4991
Published: 2009
Journal Articles

A Prospective, Observational Study on the Incidence of Chemotherapy-Induced Neutropenia in Lymphoma Patients

Antonio Salar, MD, PhD, Andrés López, Juan Pío Torres, María Dolores López, Elena Prieto, Dolores Caballero, Pilar Giraldo, MD, PhD, Montserrat Batlle, Patricia Benedit, Teresa Garrido
Journal: Blood
Blood (2008) 112 (11): 4955.
https://doi.org/10.1182/blood.V112.11.4955.4955
Published: 2008
Journal Articles

Dose Adjusted EPOCH Chemotherapy Plus Rituximab Combination (DA-R-EPOCH), an Effective Upfront Therapy for Patients with Poor-Risk Aggressive B-Cell Lymphomas. Results of a Pilot Study in a Single Center.

Andrés López, MD, Laura Gallur, MD, Andrés Palacios, MD, Mayda Navarrete, MD, Carmen Ruiz-Marcellán, MD, Josep Castellví, MD, Santiago Ramón y Cajal, MD, Antonio Juliá, MD
Journal: Blood
Blood (2005) 106 (11): 4716.
https://doi.org/10.1182/blood.V106.11.4716.4716
Published: 2005